Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Passage BIO, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- −9 vs. Q4 2022
- Shares held
- 35.5M
- −1.83M (−4.9%) vs. Q4 2022
- Total value
- $34.0M
- −$17.5M (−34.0%) vs. Q4 2022
- New holders
- 5
- 15 more added
- Sold out
- 14
- 15 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 8,931,999 | $8.55M | 0.17% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 4,959,769 | $4.75M | 9.90% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $3.60M | 0.26% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 3,407,598 | $3.26M | 2.72% | +51,681+1.5% | Added |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2.40M | 1.98% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,017,883 | $1.93M | 0.00% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 1,560,800 | $1.50M | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 1,053,999 | $1.01M | 0.00% | −69,698−6.2% | Reduced |
| Renaissance Technologies LLC | 964,900 | $924.0K | 0.00% | −226,250−19.0% | Reduced |
| Newtyn Management, LLC | 665,221 | $637.1K | 0.13% | −124,779−15.8% | Reduced |
| JPMorgan Chase & Co | 589,008 | $564.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 578,806 | $553.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 389,600 | $373.1K | 0.01% | −100,000−20.4% | Reduced |
| Weiss Multi-Strategy Advisers LLC | 367,696 | $352.0K | 0.01% | 00.0% | Unchanged |
| BML Capital Management, LLC | 337,467 | $323.2K | 0.28% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 331,914 | $317.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 310,500 | $297.4K | 0.00% | −129,600−29.4% | Reduced |
| Tang Capital Management LLC | 300,000 | $287.3K | 0.04% | +300,000 | New |
| Millennium Management LLC | 298,090 | $285.0K | 0.00% | −191,411−39.1% | Reduced |
| Two Sigma Investments, LP | 288,926 | $276.7K | 0.00% | −65,497−18.5% | Reduced |
| D. E. Shaw & Co., Inc. | 274,335 | $262.7K | 0.00% | −88,417−24.4% | Reduced |
| Morgan Stanley | 271,172 | $259.7K | 0.00% | +233,807+625.7% | Added |
| Gsa Capital Partners LLP | 130,188 | $125.0K | 0.01% | +23,352+21.9% | Added |
| State Street Corp | 123,873 | $118.6K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 115,000 | $110.1K | 0.00% | +5,000+4.5% | Added |
| RBF Capital, LLC | 110,807 | $106.1K | 0.01% | −3,400−3.0% | Reduced |
| Cornercap Investment Counsel Inc | 101,488 | $97.2K | 0.02% | +1,236+1.2% | Added |
| Marquette Asset Management, LLC | 86,050 | $82.4K | 0.02% | +18,949+28.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 82,895 | $79.4K | 0.00% | +576+0.7% | Added |
| Vontobel Holding Ltd. | 80,000 | $76.6K | 0.00% | +45,000+128.6% | Added |
| Citadel Advisors LLC | 60,978 | $58.4K | 0.00% | −30,436−33.3% | Reduced |
| Northern Trust Corp | 60,902 | $58.3K | 0.00% | +1,879+3.2% | Added |
| FMR LLC | 60,621 | $58.1K | 0.00% | +971+1.6% | Added |
| Annandale Capital, LLC | 54,338 | $52.0K | 0.02% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 47,983 | $37.0K | 0.00% | +5,149+12.0% | Added |
| Tower Research Capital LLC (TRC) | 33,049 | $32.0K | 0.00% | −10,547−24.2% | Reduced |
| Bank of America Corp | 33,168 | $31.7K | 0.00% | +14,462+77.3% | Added |
| Occudo Quantitative Strategies LP | 27,758 | $26.6K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,526 | $26.4K | 0.00% | −1,166−4.1% | Reduced |
| Deutsche Bank AG | 24,697 | $23.7K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 23,045 | $22.1K | 0.00% | +23,045 | New |
| HRT Financial LP | 19,723 | $18.0K | 0.00% | +19,723 | New |
| Dimensional Fund Advisors LP | 18,114 | $17.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 16,568 | $15.9K | 0.00% | +4,296+35.0% | Added |
| Bank of New York Mellon Corp | 13,647 | $13.1K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 13,153 | $12.6K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 10,129 | $9.70K | 0.00% | −3,956−28.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 8,000 | $7.66K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,277 | $3.14K | 0.00% | −2,415−42.4% | Reduced |
| Advisor Group Holdings, Inc. | 1,607 | $1.54K | 0.00% | +992+161.3% | Added |
| Wells Fargo & Company | 534 | $511 | 0.00% | +304+132.2% | Added |
| US Bancorp | 500 | $479 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 100 | $96 | 0.00% | −200−66.7% | Reduced |
| Point72 Asset Management, L.P. | 89 | $85 | 0.00% | +89 | New |
| Clearstead Advisors, LLC | 75 | $72 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 122 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 318 | $0 | 0.00% | +318 | New |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −822,105−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −240,000−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −182,978−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −156,900−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −49,114−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −37,806−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −22,661−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,728−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,761−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −198−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Investors Research Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −20−100.0% | Sold out |